Business · 11/12/2020Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 10 Abbreviated New Drug Applications from VistaPharm, Inc. and Others
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 10 abbreviated new drug applications (ANDAs) from multiple pharmaceutical companies, including VistaPharm, Inc., following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →